Dr. Breanne Everett Recognized for Big Ideas and Bold Leadership

Calgary, AB Canada – September 15, 2026 — Everett’s path to becoming an entrepreneur did not begin with a business plan. It began with patients.
While training as a plastic and reconstructive surgeon, Everett saw people living with diabetes lose their legs to wounds, losses that might have been prevented. This left her wondering whether there was a better way to intervene before the damage was done.
Everett co-founded Calgary-based Orpyx Medical Technologies in 2010. Today, as CEO, she leads a team developing sensorized insoles and remote-monitoring technology to help prevent wounds and amputations in people with diabetes.
The system collects data on what is happening beneath the foot during everyday activity, including pressure, temperature and movement, and provides real-time feedback and ongoing monitoring.
Everett’s work has earned recognition well beyond the medical community. Her honours include the Governor General’s Innovation Award, Alberta Business Hall of Fame’s Southern Alberta Innovator Award, Alberta Women Entrepreneur Upsurge Entrepreneur Award and Calgary Award in Commerce.
She has also been named to Avenue Magazine’s Top 40 Under 40 and Canada’s Top 100 Most Powerful Women, and was recognized by UCalgary as a Graduate of the Last Decade.
A Loran National Scholar, Everett remains active with the Loran Alumni Community, and has served on the Canadian Medical Association’s Joule Innovation Council and the Governor General Innovation Award Selections Committee.
“There’s a lot of meaning that comes from being able to apply your energy to an area that you’re passionate about,” she says. “And that’s what keeps me going.”
Read the full story from the University of Calgary: Where opportunity leads
Orpyx Medical Technologies Supplies Digital Health Platform for NIH-Funded and Johns Hopkins Medicine–Led Clinical Trial on Diabetic Foot Ulcer Prevention

The Honorable David Shulkin, M.D. Joins Orpyx Advisory Board to Advance Veteran Care and Diabetes Prevention Market Growth

Orpyx Launches Sensory Insole Program to Combat >$80B Annual Cost of Diabetic Foot Complications
